Ellagic Acid: Benefits, Evidence, and What It Actually Does in the Body

A polyphenol found in pomegranates, berries, and nuts that gets converted by gut bacteria into compounds called urolithins, which may explain most of its effects.

Track the foods that fit your goals. Track it free with Ration →

By the Ration Editorial Team · Reviewed against primary research · Updated July 13, 2026

Ellagic acid is a naturally occurring polyphenol found in a range of fruits and nuts.

It is especially concentrated in pomegranates, where it exists largely bound up in larger molecules called ellagitannins.^[5]

Other sources include:

• Pomegranates and pomegranate juice
• Walnuts and pecans
• Strawberries and raspberries
• Blackberries
• Green tea in smaller amounts

On its own, ellagic acid is not especially well absorbed or bioactive. Most of its reputed benefits depend on what happens to it after it reaches the gut.

When you eat pomegranate or other ellagitannin-rich foods, the ellagitannins break down into free ellagic acid in the digestive tract.

Gut bacteria then metabolize that ellagic acid into a family of compounds called urolithins.^[3][4]

This step matters a lot. Not everyone's gut microbiome produces urolithins efficiently, and the type and amount of urolithins a person makes appears to depend heavily on their individual microbiota.^[3]

Because of this, some researchers now think of urolithins, rather than ellagic acid itself, as the more biologically active end product worth studying.^[4]

Mechanistically, ellagic acid and its metabolites have been studied for their antioxidant activity and their ability to modulate inflammatory pathways, including the NLRP3 inflammasome, a key driver of inflammation in conditions like ulcerative colitis.^[2]

Much of the research on ellagic acid so far comes from animal models and lab studies, rather than large human trials.

In a 2025 study using a mouse model of metabolic dysfunction-associated steatotic liver disease (MASLD), pomegranate-derived nanovesicles containing ellagic acid helped reduce gut barrier leakage and liver injury.^[1]

Another 2025 study found that pomegranate peel extract and ellagic acid reduced markers of ulcerative colitis in an animal model, apparently by acting on the AKR1B1/B3 enzymes to dampen NLRP3 inflammasome activity.^[2]

A broader review of urolithins summarized evidence on their metabolism, gut microbiota interactions, and biological activity, underscoring how variable urolithin production is between individuals.^[3]

Older human-relevant work has looked at ellagic acid consumption and its conversion into urolithins in the context of metabolic health, though the authors describe the evidence as still developing rather than conclusive.^[4]

For blood pressure specifically, our database tracks five sources pointing toward a modest decrease in systolic blood pressure with ellagic acid exposure, but grades this evidence 'D', meaning the signal is weak and inconsistent across the available research.

• ↓Systolic Blood PressureDPreliminary

  Research may lower Systolic Blood Pressure · strong agreement · 5 studies

  View 5 studies on PubMed

  • Pomegranate-Derived Exosome-Like Nanovesicles Containing Ellagic Acid Alleviate Gut Leakage and Liver Injury in MASLD (2025)
  • Pomegranate Ellagitannins (2011)
  • Improvements in Metabolic Health with Consumption of Ellagic Acid and Subsequent Conversion into Urolithins: Evidence and Mechanisms (2016)
  • Urolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut Microbiota (2022)
  • Pomegranate peel and ellagic acid attenuate ulcerative colitis by targeting AKR1B1/B3 to inhibit NLRP3 (2025)

Taken together, the picture is one of a promising compound with clear biological activity in cells and animals, but human trial data that has not yet caught up.

Some research has explored whether ellagic acid or pomegranate polyphenols more broadly might support healthy blood pressure.

Our database reflects a consensus direction toward decreased systolic blood pressure, based on five sources, but with a low evidence grade of D.

That grade matters. It suggests the studies behind this signal are limited in size, consistency, or study design quality, so this should be read as a hypothesis worth more research rather than an established effect.

Ellagic acid is not typically taken as an isolated supplement in the way something like vitamin C or magnesium might be.

Most people encounter it through:

• Whole pomegranates or 100% pomegranate juice
• Pomegranate extract capsules
• Walnuts
• Berries, especially raspberries and strawberries
• Pomegranate peel extract, studied specifically for gut and liver effects^[1][2]

Some newer research is exploring more targeted delivery methods, such as pomegranate-derived exosome-like nanovesicles that carry ellagic acid directly to tissues like the gut and liver.^[1] These remain experimental and are not available as consumer products.

Ellagic acid is consumed regularly as part of a normal diet through fruits and nuts, and there is no strong signal of harm at typical dietary intakes.

Most of the safety data comes from studies of pomegranate extract or whole pomegranate products rather than isolated high-dose ellagic acid.^[5]

Because individual gut microbiomes convert ellagic acid into urolithins so differently, the practical effects of any given dose may vary meaningfully from person to person.^[3][4]

This is a food-based compound rather than a drug, and it should be thought of that way. It is not a substitute for medical treatment of high blood pressure, liver disease, or inflammatory bowel conditions.

People already eating pomegranates, berries, or walnuts as part of a varied diet are likely getting meaningful ellagic acid exposure without needing to think about it separately.

Those specifically interested in the gut-liver-inflammation research may be curious about pomegranate extract or peel-derived products, though the strongest evidence for these remains preclinical.^[1][2]

Anyone considering a concentrated ellagic acid or urolithin supplement for a specific health condition should treat the current evidence as early-stage.

Ellagic acid is a well-studied plant polyphenol with genuine biological activity, largely mediated through its conversion into urolithins by gut bacteria.^[3][4]

Animal and cell research suggests potential benefits for gut barrier integrity, liver health, and inflammatory conditions like ulcerative colitis.^[1][2]

Human evidence, including for blood pressure, remains limited and is graded low confidence in the research we track.

Eating pomegranates, berries, and walnuts remains a reasonable way to get ellagic acid alongside other beneficial nutrients, while more targeted supplement claims deserve a wait and see approach.